Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors

Mancini, Manuela, De Santis, Sara, Monaldi, Cecilia · Frontiers in Oncology · 2022